Sanna A, Phung B, Mitra S, Lauss M, Choi J, Zhang T, Njauw CN, Cordero E, Harbst K, Rosengren F, Cabrita R, Johansson I, Isaksson K, Ingvar C, Carneiro A, Brown K, Tsao H, Andersson M, Pietras K, Jönsson G

DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.
JCI Insight. 2022;7(19):ePub - PMID: 36040798 - PMCID: PMC9675437 - DOI: 10.1172/jci.insight.156577

Rashid S, Gupta S, McCormick SR, Tsao H

New Insights into Melanoma Tumor Syndromes.
JID Innov. 2022;2(6):100152 - PMID: 36387771 - PMCID: PMC9641259 - DOI: 10.1016/j.xjidi.2022.100152

Jobbagy S, Chaudet KM, Gayhart M, Klepeis VE, Boland G, Tsao H, Duncan LM

Resilience of melanoma diagnostics at a tertiary-care hospital during the SARS-CoV-2 pandemic.
JAAD Int. 2022;9:78-79 - PMID: 36061239 - PMCID: PMC9428333 - DOI: 10.1016/j.jdin.2022.08.012

Rashid S, Shaughnessy M, Tsao H

Melanoma classification and management in the era of molecular medicine.
Dermatol Clin. 2022;41(1):49-63 - PMID: 36410983 - DOI: 10.1016/j.det.2022.07.017

Kang Y, Ji Z, Li H, Tsao H

Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping.
J Invest Dermatol. 2022;143(5):842-853.e6 - PMID: 36529262 - DOI: 10.1016/j.jid.2022.03.039
5